BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Elite Pharmaceuticals, Inc. 

165 Ludlow Avenue

Northvale  New Jersey  07647  U.S.A.
Phone: 201-750-2646 Fax: 201-750-2755


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The First Quarter Of Fiscal Year 2015 8/15/2014 7:59:54 AM
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On August 18, 2014 8/13/2014 7:31:02 AM
Elite Pharmaceuticals, Inc. (ELI) Initiates Pivotal Bioequivalence Study For ELI-201 7/15/2014 10:24:57 AM
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The Fiscal Year Ended March 31, 2014 7/1/2014 10:26:27 AM
Elite Pharmaceuticals, Inc. (ELI) To Host 2014 Fiscal Year End Conference Call On Tuesday, July 1, 2014 6/27/2014 7:29:54 AM
Elite Pharmaceuticals, Inc. (ELI) Enters Into $5 Million Settlement Agreement With Novel Laboratories, LLC 6/11/2014 7:16:35 AM
Elite Pharmaceuticals, Inc. (ELI) Begins Human Abuse Liability Studies For ELI-200 6/9/2014 9:12:42 AM
Elite Pharmaceuticals, Inc. (ELI) Announces Results Of 2014 Annual Meeting Of Shareholders 5/23/2014 9:58:15 AM
Elite Pharmaceuticals, Inc. (ELI) Initiates Pivotal Bioequivalence Study For Third Opioid Abuse Deterrent Product 5/19/2014 9:26:22 AM
Elite Pharmaceuticals, Inc. (ELI) Showing Long Term Promise, Analyst Report By BrokerBank Securities, Inc. 5/5/2014 8:31:49 AM
12345678910...